Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Fetal Monitoring Analysis Market Research Report by Product, Method, Portability, End-use, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Fetal Monitoring Analysis Market size was estimated at USD 3,256.78 million in 2020, is expected to reach USD 3,593.70 million in 2021, and projected to grow at a CAGR of 10.68% reaching USD 5,988.08 million by 2026.
Market Statistics
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage
This research report categorizes the Fetal Monitoring Analysis to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Product, the market was studied across Accessories & Consumables, Electronic Fetal Monitoring, Fetal Doppler, Fetal Electrodes, Instruments & Consumables, Software, Telemetry Solutions, Ultrasound & Ultrasonography, and Uterine Contraction Monitor.
- Based on Method, the market was studied across Invasive and Non-invasive.
- Based on Portability, the market was studied across Non Portable Systems and Potable.
- Based on End-use, the market was studied across Clinics and Hospitals.
- Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Competitive Strategic Window
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Fetal Monitoring Analysis Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Fetal Monitoring Analysis Market, including Advanced Instrumentations, Bionet Co., Ltd., BISTOS, BRAEL-Medical Equipment, Cardinal Health, Inc., ChoiceMMed, CONTEC Medical Systems Co., Ltd., Dixion, Dott Medical Co. Ltd., EDAN Diagnostics, Inc., FUJIFILM SonoSite, Inc., GE Healthcare, GPC Medical, Huntleigh Healthcare Limited, Koninklijke Philips N.V., Life Plus, MedGyn Products, Inc, Mediana, Monarch Meditech, Natus Medical Incorporated, Neoventa Medical AB, Progetti Srl, Promed Group Co., Ltd., Shenzhen Comen Medical Instruments Co., Ltd., ShenZhen Luckcome Technology Inc., Siemens Healthineers, The Cooper Companies Inc., TRISMED Co., Ltd., and Trivitron Healthcare.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Fetal Monitoring Analysis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Fetal Monitoring Analysis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Fetal Monitoring Analysis Market?
4. What is the competitive strategic window for opportunities in the Global Fetal Monitoring Analysis Market?
5. What are the technology trends and regulatory frameworks in the Global Fetal Monitoring Analysis Market?
6. What is the market share of the leading vendors in the Global Fetal Monitoring Analysis Market?
7. What modes and strategic moves are considered suitable for entering the Global Fetal Monitoring Analysis Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Growing prevalence of cardiopulmonary diseases
5.2.2. Increase in the number of post-term pregnancy, multiple pregnancy, and premature delivery cases
5.2.3. Government and non-government initiatives for maternal & fetal health
5.3. Restraints
5.3.1. High cost associated with the equipment
5.4. Opportunities
5.4.1. Technological advancements and new innovative product launches
5.4.2. Rising manufactures awareness & willingness to invest in the development of fetal monitoring
5.5. Challenges
5.5.1. Stringent regulatory procedures and death of intervening guidelines
6. Fetal Monitoring Analysis Market, by Product
6.1. Introduction
6.2. Accessories & Consumables
6.3. Electronic Fetal Monitoring
6.4. Fetal Doppler
6.5. Fetal Electrodes
6.6. Instruments & Consumables
6.7. Software
6.8. Telemetry Solutions
6.9. Ultrasound & Ultrasonography
6.10. Uterine Contraction Monitor
7. Fetal Monitoring Analysis Market, by Method
7.1. Introduction
7.2. Invasive
7.3. Non-invasive
8. Fetal Monitoring Analysis Market, by Portability
8.1. Introduction
8.2. Non Portable Systems
8.3. Potable
9. Fetal Monitoring Analysis Market, by End-use
9.1. Introduction
9.2. Clinics
9.3. Hospitals
10. Americas Fetal Monitoring Analysis Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Fetal Monitoring Analysis Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Fetal Monitoring Analysis Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, by Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Advanced Instrumentations
14.2. Bionet Co., Ltd.
14.3. BISTOS
14.4. BRAEL-Medical Equipment
14.5. Cardinal Health, Inc.
14.6. ChoiceMMed
14.7. CONTEC Medical Systems Co., Ltd.
14.8. Dixion
14.9. Dott Medical Co. Ltd.
14.10. EDAN Diagnostics, Inc.
14.11. FUJIFILM SonoSite, Inc.
14.12. GE Healthcare
14.13. GPC Medical
14.14. Huntleigh Healthcare Limited
14.15. Koninklijke Philips N.V.
14.16. Life Plus
14.17. MedGyn Products, Inc.
14.18. Mediana
14.19. Monarch Meditech
14.20. Natus Medical Incorporated
14.21. Neoventa Medical AB
14.22. Progetti Srl
14.23. Promed Group Co., Ltd.
14.24. Shenzhen Comen Medical Instruments Co., Ltd.
14.25. ShenZhen Luckcome Technology Inc.
14.26. Siemens Healthineers
14.27. The Cooper Companies Inc.
14.28. TRISMED Co., Ltd.
14.29. Trivitron Healthcare
15. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/ineihr
